1
|
Roberto E, De Maggi A, Dalmasso F, Bergesio F, Peano E, Balderi A, Chauvie S. Intraoperative uterine iliac artery embolization in planned caesarean for accreta placenta: estimation of foetal radiation dose in a case report. Phys Med 2021. [DOI: 10.1016/s1120-1797(22)00507-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
2
|
Milan L, Cascione L, Dalmasso F, Giovanella L, Chauvie S, Zucca E, Ceriani L. A validated PET radiomics model predicts outcome of diffuse large B cell lymphoma: post-hoc analysis from the SAKK38/07 clinical trial. Phys Med 2021. [DOI: 10.1016/s1120-1797(22)00197-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
3
|
Gallamini A, Rambaldi A, Patti C, Romano A, Viviani S, Bolis S, Oppi S, Trentin L, Cantonetti M, Sorasio R, Gavarotti P, Gottardi D, Schiavotto C, Battistini R, Gini G, Ferreri A, Pavoni C, Bergesio F, Ficola U, Guerra L, Chauvie S. BASELINE METABOLIC TUMOR VOLUME AND IPS PREDICT ABVD FAILURE IN ADVANCED‐STAGE HODGKIN LYMPHOMA WITH A NEGATIVE INTERIM PET SCAN AFTER 2 CHEMOTHERAPY CYCLES. A RETROSPECTIVE ANALYSIS FROM THE GITIL/FIL HD0607 TRIAL. Hematol Oncol 2021. [DOI: 10.1002/hon.19_2879] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- A Gallamini
- Antoine Lacassagne Cancer Center Research and Clinical Innovation Nice France
| | - A Rambaldi
- Ospedale Papa Giovanni XXIII Hematology Bergamo Italy
| | - C Patti
- Ospedali Riuniti di Palermo Hematology Palermo Italy
| | - A Romano
- Policlinico Universitario A. Ferrarotto Hematology Catania Italy
| | - S Viviani
- Istituto Europeo di Ematologia Hematology Milano Italy
| | - S Bolis
- Ospedale S. Gerardo Hematology Monza Italy
| | - S Oppi
- Ospedale Antonio Businco Hematology Cagliari Italy
| | - L Trentin
- Azienda Ospedaliera di Padova Hematology Padova Italy
| | | | - R Sorasio
- Ospedale S. Croce e Carle Hematology Cuneo Italy
| | - P Gavarotti
- Ospedale S. Giovanni Battista Hematology ‐ University Torino Italy
| | - D Gottardi
- Ospedale Mauriziano Hematology Torino Italy
| | | | - R Battistini
- Ospedale S. Camillo Forlanini Hematology Roma Italy
| | - G Gini
- Ospedali Riuniti di Ancona Hematology Ancona Italy
| | | | - C Pavoni
- Ospedale Papa Giovanni XXIII Hematology Bergamo Italy
| | - F Bergesio
- Ospedale S. Croce e Carle Medical Physics Cuneo Italy
| | - U Ficola
- Ospedale La Maddalena Nuclear Medicine Palermo Italy
| | - L Guerra
- Ospedale S. Gerardo Nuclear Medicine Monza Italy
| | - S Chauvie
- Ospedale S. Croce e Carle Medical Physics Cuneo Italy
| |
Collapse
|
4
|
Gallamini A, Walewski J, Rambaldi A, Viviani S, Sureda A, André M, Rossi C, Moccia A, Zucca E, Rossi D, Filippi A, Meignan M, Chauvie S, Zaucha JM. RADIATION FREE THERAPY OR THE INITIAL TREATMENT OF GOOD PROGNOSIS EARLY NON‐BULKY HODGKIN LYMPHOMA, DEFINED BY A LOW METABOLIC TUMOR VOLUME AND A NEGATIVE PET‐2 ‐ RAFTING TRIAL. Hematol Oncol 2021. [DOI: 10.1002/hon.158_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- A. Gallamini
- Antoine Lacassagne Cancer Center Research and Clinical Innovation Nice France
| | - J. Walewski
- Marii Skłodowskiej‐Curie Institute Onco‐Hematology Warsaw Poland
| | - A. Rambaldi
- Ospedale Papa Giovanni XXIII Hematology Bergamo Italy
| | - S. Viviani
- Istituto Europeo di Ematologia Hematology Milano Italy
| | - A. Sureda
- Institut Català d'Oncologia Hematology Barcelona Spain
| | - M. André
- Cliniques universitaires Saint‐Luc ‐ UC Louvain Hematology Louvain Belgium
| | - C. Rossi
- CHU Bocage Hematology Dijon France
| | - A. Moccia
- Istituto Oncologico della Svizzera Italiana Hematology Bellinzona Switzerland
| | - E. Zucca
- Istituto Oncologico della Svizzera Italiana Hematology Bellinzona Switzerland
| | - D. Rossi
- Istituto Oncologico della Svizzera Italiana Hematology Bellinzona Switzerland
| | - A. Filippi
- Policlinico S. Matteo IRCCS Radiation Oncology Pavia Italy
| | - M. Meignan
- Henry Mondor Hospital LYSA Imaging Paris France
| | - S. Chauvie
- Ospedale S. Croce e Carle Medical Physics Cuneo Italy
| | - J. M. Zaucha
- Medical University of Gdansk Hematology Gdansk Poland
| |
Collapse
|
5
|
Ceriani L, Milan L, Cascione L, Gritti G, Dalmasso F, Esposito F, Schär S, Bruno A, Dirnhofer S, Giovanella L, Hayoz S, Mamot C, Rambaldi A, Chauvie S, Zucca E. DEVELOPMENT AND VALIDATION OF A PET RADIOMICS PROGNOSTIC MODEL FOR DIFFUSE LARGE B CELL LYMPHOMA. Hematol Oncol 2021. [DOI: 10.1002/hon.22_2879] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- L Ceriani
- Ente Ospedaliero Cantonale Clinic of Nuclear Medicine and PET/CT Center Lugano Switzerland
| | - L Milan
- Ente Ospedaliero Cantonale Clinic of Nuclear Medicine and PET/CT Center Lugano Switzerland
| | - L Cascione
- Università della Svizzera Italiana Institute of Oncology Research Faculty of Biomedical Sciences Bellinzona Switzerland
| | - G Gritti
- Azienda Ospedaliera Papa Giovanni XXIII Hematology Unit Bergamo Italy
| | - F Dalmasso
- Santa Croce e Carle Hospital Medical Physics Unit Cuneo Italy
| | - F Esposito
- Ente Ospedaliero Cantonale Institute of Southern Switzerland Clinic of Medical Oncology Bellinzona Switzerland
| | - Säm Schär
- Swiss Group for Clinical Cancer Research (SAKK) Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center Bern Switzerland
| | - A Bruno
- Azienda Ospedaliera Papa Giovanni XXIII Department of Nuclear Medicine Bergamo Italy
| | - S Dirnhofer
- University Hospital Basel Institute of Medical Genetics and Pathology Basel Switzerland
| | - L Giovanella
- Ente Ospedaliero Cantonale Clinic of Nuclear Medicine and PET/CT Center Lugano Switzerland
| | - S Hayoz
- Swiss Group for Clinical Cancer Research (SAKK) Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center Bern Switzerland
| | - C Mamot
- Cantonal Hospital Aarau Division of Oncology Aarau Switzerland
| | - A Rambaldi
- Azienda Ospedaliera Papa Giovanni XXIII Hematology Unit Bergamo Italy
| | - S Chauvie
- Santa Croce e Carle Hospital Medical Physics Unit Cuneo Italy
| | - E Zucca
- Ente Ospedaliero Cantonale Institute of Southern Switzerland Clinic of Medical Oncology Bellinzona Switzerland
| |
Collapse
|
6
|
Spina V, Pirosa MC, Bruscaggin A, Condoluci A, Pini K, Forestieri G, Zangrilli I, di Trani M, Kurlapski M, Moccia A, Moia R, Bulian P, Annunziata S, Borsatti E, Rodari M, Romanowicz G, Sacchetti GM, Faderl M, Koch R, Piffaretti D, Terzi di Bergamo L, Stasia A, Cittone M, Chauvie S, Stüssi G, Gerber B, Stathis A, Sommer SG, Cavalli F, Zucca E, Gattei V, Zaucha JM, Pinto A, Gaidano G, Carlo‐Stella C, Hohaus S, Ceriani L, Rossi D. CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER IN CLASSIC HODGKIN LYMPHOMA. Hematol Oncol 2021. [DOI: 10.1002/hon.70_2879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
7
|
Luminari S, Guerra L, Durmo R, Chauvie S, Peano S, Franceschetto A, Fallanca F, Tarantino V, Pinto A, Ghiggi C, Pulsoni A, Merli M, Farina L, Tani M, Botto B, Musuraca G, Falini B, Ballerini F, Stefani PM, Bolis S, Pietrantuono G, Manni M, Marcheselli L, Federico M, Versari A. EARLY METABOLIC RESPONSE IN FOLLICULAR LYMPHOMA: A SUBSET ANALYSIS OF THE FOLL12 TRIAL BY THE FONDAZIONE ITALIANA LINFOMI (FIL). Hematol Oncol 2021. [DOI: 10.1002/hon.33_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- S. Luminari
- Azienda Unità Sanitaria Locale IRCCS Arcispedale Santa Maria Nuova IRCCS, Hematology Unit and University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant Oncology and Regenerative Medicine Reggio Emilia Italy
| | - L. Guerra
- S. Gerardo Hospital University of Milano‐Bicocca, Nuclear Medicine and , University of Milano Bicocca School of Medicine and Surgery Monza Italy
| | - R. Durmo
- Azienda USL‐IRCCS di Reggio Emilia Nuclear Medicine Reggio Emilia Italy
| | - S. Chauvie
- Santa Croce e Carle Hospital Department of Medical Physics Cuneo Italy
| | - S. Peano
- ASO S. Croce e Carle S.C. Medicina Nucleare Cuneo Italy
| | - A. Franceschetto
- Modena Cancer Center University of Modena and Reggio Emilia Department of Oncology and Hematology Unit of Nuclear Medicine Modena Italy
| | - F. Fallanca
- IRCCS San Raffaele Scientific Institute Nuclear Medicine Unit Milano Italy
| | - V. Tarantino
- University of Modena and Reggio Emilia PhD program in Clinical and Experimental Medicine (CEM) Modena Italy
| | - A. Pinto
- National Cancer Institute Fondazione "G. Pascale" IRCCS Hematology‐Oncology and Stem Cell Transplantation Unit Napoli Italy
| | - C. Ghiggi
- IRCCS San Martino Hospital Hematology and Transplant Center Division Genoa Italy
| | - A. Pulsoni
- Sapienza Università di Roma Dipartimento di Biotecnologie Cellulari ed Ematologia Roma Italy
| | - M. Merli
- University Hospital Ospedale di Circolo e Fondazione Macchi ASST Settelaghi Varese Italy
| | - L. Farina
- Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Division of Hematology Milano Italy
| | - M. Tani
- Ospedale Civile S Maria delle Croci Azienda Unità Sanitaria Locale (AUSL) Ravenna Italy
| | - B. Botto
- A.O.U. Città della Salute e della Scienza di Torino SC Ematologia Torino Italy
| | - G. Musuraca
- IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori" Department of Hematology Meldola Italy
| | - B. Falini
- University of Perugia, Institute of Hematology and CREO (Center for Hemato‐Oncological Research) Ospedale S. Maria della Misericordia Perugia Italy
| | - F. Ballerini
- IRCCS Ospedale Policlinico San Martino University of Genoa Clinica Ematologica Genova Italy
| | - P. M. Stefani
- General Hospital Ca' Foncello Hematology Treviso Italy
| | - S. Bolis
- ASST MONZA, SC di Ematologia Monza Italy
| | - G. Pietrantuono
- IRCCS Centro di Riferimento Oncologico della Basilicata Hematology and Stem Cell Transplantation Unit Rionero in Vulture Italy
| | - M. Manni
- University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant Oncology and Regenerative Medicine Modena Italy
| | | | - M. Federico
- University of Modena and Reggio Emilia Surgical, Medical and Dental Department of Morphological Sciences related to Transplant Oncology and Regenerative Medicine Modena Italy
| | - A. Versari
- Azienda USL‐IRCCS di Reggio Emilia Nuclear Medicine Reggio Emilia Italy
| |
Collapse
|
8
|
Gallamini A, Rossi A, Patti C, Picardi M, Romano A, Cantonetti M, Oppi S, Viviani S, Bolis S, Trentin L, Gini G, Battistini R, Chauvie S, Bertolotti L, Pavoni C, Parvis G, Zanotti R, Gavarotti P, Cimminiello M, Schiavotto C, Viero P, Avigdor A, Tarella C, Rambaldi A. CONSOLIDATION RADIOTHERAPY COULD BE OMITTED IN ADVANCED HODGKIN LYMPHOMA WITH LARGE NODAL MASS IN COMPLETE METABOLIC RESPONSE AFTER ABVD. FINAL ANALYSIS OF THE RANDOMIZED HD0607 TRIAL. Hematol Oncol 2019. [DOI: 10.1002/hon.105_2629] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- A. Gallamini
- Research & Clinical Innovation; Antoine Lacassagne Cancer Centre; Nice France
| | - A. Rossi
- Department of Oncology-Hematology; University of Milan and Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII; Bergamo Italy
| | - C. Patti
- Hematology; V. Cervello Hospital; Palermo Italy
| | - M. Picardi
- Hematology; Policlinico Federico II; Naples Italy
| | - A. Romano
- Hematology; Policlinico Vittorio Emanuele Hospital; Catania Italy
| | - M. Cantonetti
- Hematology; Policlinico Hospital Tor Vergata; Rome Italy
| | - S. Oppi
- Hematology; Businco Oncology Hospital; Cagliari Italy
| | - S. Viviani
- Hematology; National Institute of tumors; Milan Italy
| | - S. Bolis
- Hematology; S. Gerardo University Hospital; Monza Italy
| | | | - G. Gini
- Hematology; Ospedali Riuniti Le Torrette; Ancona Italy
| | - R. Battistini
- Hematology; S. Camillo Forlanini Hospital; Rome Italy
| | - S. Chauvie
- Medical Physics; S. Croce Hospital; Cuneo Italy
| | | | - C. Pavoni
- Department of Oncology-Hematology; University of Milan and Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII; Bergamo Italy
| | - G. Parvis
- Hematology; Mauriziano Hospital; Turin Italy
| | - R. Zanotti
- Hematology; Azienda Ospedaliera Universitaria Integrata; Verona Italy
| | - P. Gavarotti
- Hematology; University Hospital Città della salute; Turin Italy
| | | | | | - P. Viero
- Hematology; Dell'Angelo Hospital; Venice Italy
| | - A. Avigdor
- Hematolog and Bone Marrow Transplantation; Sheba Medical Center; Tel-Aviv Israel
| | - C. Tarella
- Hematology; European Institute of Oncology; Milan Italy
| | - A. Rambaldi
- Department of Oncology-Hematology; University of Milan and Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII; Bergamo Italy
| |
Collapse
|
9
|
Balzarotti M, Ricardi U, Spina M, Monagheddu C, Tucci A, Cavallo F, Zanni M, Arcari A, Rusconi C, Sartori R, Merli F, Re F, Vitolo U, Dessi D, Melis L, Gaidano G, Chiti A, Deidda M, Santoro A, Ciccone G, Chauvie S, Cabras M. PET-DRIVEN RADIOTHERAPY IN PATIENTS WITH LOW RISK DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): THE DLCL10 MULTICENTER PHASE 2 TRIAL BY FONDAZIONE ITALIANA LINFOMI (FIL). Hematol Oncol 2019. [DOI: 10.1002/hon.62_2630] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- M. Balzarotti
- Medical Oncology and Hematology; Humanitas Clinical and Research Hospital-IRCCS-Humanitas University; Rozzano Milano Italy
| | - U. Ricardi
- Radiotherapy; AOU Città della Salute e della Scienza, University of Torino; Torino Italy
| | - M. Spina
- Medical Oncology; IRCCS CRO; Aviano (PN) Italy
| | - C. Monagheddu
- Epidemiologia Clinica e Valutativa; AOU Città della Salute e della Scienza e CPO; Torino Italy
| | - A. Tucci
- Hematology; Spedali Civili; Brescia
| | - F. Cavallo
- Hematology; Universita' Citta' della Salute e della Scienza; Torino Italy
| | - M. Zanni
- Hematology; ASO ss Antonio e Biagio e Arrigo; Alessandria Italy
| | - A. Arcari
- Hematology; Ospedale Guglielmo da Saliceto; Piacenza Italy
| | - C. Rusconi
- Hemtaology; ASST Grande Ospedale Metropolitano Niguarda; Milano Italy
| | - R. Sartori
- Hematology; Azienda ULSS 2 Marca Trevigiana; Castelfranco Veneto Treviso Italy
| | - F. Merli
- Hematology; Arcispedale Santa Maria Nuova; Reggio Emilia Italy
| | - F. Re
- Hematology; AOU Parma; Parma Italy
| | - U. Vitolo
- Hematology; AO Città della Salute e della Scienza; Torino Italy
| | - D. Dessi
- Hematology; Ospedale Oncologico Armando Businco; Cagliari Italy
| | - L. Melis
- Nuclear Medicine; Ospedale Oncologico Armando Businco; Cagliari Italy
| | - G. Gaidano
- Hematology; AOU Maggiore della Carità di Novara; Novara Italy
| | - A. Chiti
- Nuclear Medicine; Humanitas Clinical and Research Hospital-IRCCS - Humanitas University; Rozzano Milano Italy
| | - M. Deidda
- Radiotherapy; Ospedale Oncologico Armando Businco; Cagliari Italy
| | - A. Santoro
- Medical Oncology and Hematology; Humanitas Clinical and Research Hospital-IRCCS-Humanitas University; Rozzano Milano Italy
| | - G. Ciccone
- Epidemiologia Clinica e Valutativa; AOU Città della Salute e della Scienza e CPO; Torino Italy
| | - S. Chauvie
- Medical Physics; Santa Croce e Carle Hospital; Cuneo Italy
| | - M. Cabras
- Hematology; Ospedale Oncologico Armando Businco; Cagliari Italy
| |
Collapse
|
10
|
Federico M, Mannina D, Versari A, Ferrero S, Marcheselli L, Boccomini C, Dondi A, Tucci A, Guerra L, Galimberti S, Cavallo F, Olivieri J, Corradini P, Arcaini L, Chauvie S, Del Giudice I, Rusconi C, Pinto A, Molinari A, Pulsoni A, Merli M, Kovalchuk S, Nassi L, Bolis S, Gattei V, Manni M, Pileri S, Brugiatelli M, Luminari S. RESPONSE ORIENTED MAINTENANCE THERAPY IN ADVANCED FOLLICULAR LYMPHOMA. RESULTS OF THE INTERIM ANALYSIS OF THE FOLL12 TRIAL CONDUCTED BY THE FONDAZIONE ITALIANA LINFOMI. Hematol Oncol 2019. [DOI: 10.1002/hon.110_2629] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- M. Federico
- Dipartimento Chirurgico, Medico, Odontoiatrico e di Scienze Morfologiche; University of Modena and Reggio Emilia; Modena Italy
| | - D. Mannina
- UOC di Ematologia; Azienda Ospedaliera Papardo; Messina Italy
| | - A. Versari
- Nuclear Medicine Unit; AUSL-IRCCS of Reggio Emilia; Reggio Emilia Italy
| | - S. Ferrero
- Department of Molecular Biotechnologies and Health Sciences, Division of Hematology; University of Torino; Torino Italy
| | - L. Marcheselli
- Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto; Fondazione Italiana Linfomi; Modena Italy
| | - C. Boccomini
- SC Ematologia; AOU Città della Salute e della Scienza di Torino; Torino Italy
| | - A. Dondi
- Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto; Fondazione Italiana Linfomi; Modena Italy
| | - A. Tucci
- SC Ematologia; ASST-Spedali Civili; Brescia Italy
| | - L. Guerra
- Nuclear Medicine Unit; San Gerardo Hospital; Monza Italy
| | - S. Galimberti
- Division of Hematology, Department of Oncology; Santa Chiara Hospital; Pisa Italy
| | - F. Cavallo
- Division of Hematology; University of Torino, Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino; Torino Italy
| | - J. Olivieri
- Clinica Ematologica; Centro Trapianti e Terapie Cellulari “C. Melzi”, DAME, ASUI; Udine Italy
| | - P. Corradini
- Department of Oncology and Hematology; Fondazione Istituto Nazionale dei Tumori Milano University of Milano; Milano Italy
| | - L. Arcaini
- Department of Molecular Medicine; University of Pavia, Division of Hematology, Fondazione IRCCS Policlinico S. Matteo; Pavia Italy
| | - S. Chauvie
- Medical Physics Unit; Azienda Ospedaliera S. Croce e Carle; Cuneo Italy
| | - I. Del Giudice
- Hematology Unit, Department of Translational and Precision Medicine; Sapienza University of Rome; Roma Italy
| | - C. Rusconi
- Division of Hematology; ASST Grande ospedale Metropolitano Niguarda; Milano Italy
| | - A. Pinto
- Department of Hematology and Developmental Therapeutics; Istituto Nazionale Tumori, Fondazione ‘G. Pascale’ IRCCS; Napoli Italy
| | - A. Molinari
- UO Ematologia; OC Rimini AUSL Romagna; Rimini Italy
| | - A. Pulsoni
- Hematology Unit, Department of Translational and Precision Medicine; Sapienza University of Rome; Roma Italy
| | - M. Merli
- Hematology; University Hospital "Ospedale di Circolo e Fondazione Macchi" - ASST Sette Laghi, University of Insubria; Varese Italy
| | - S. Kovalchuk
- Ematologia; Università degli Studi di Firenze; Firenze Italy
| | - L. Nassi
- Hematology; AOU Maggiore della Carità; Novara Italy
| | - S. Bolis
- Hematolgy Unit; ASST-Monza; Monza Italy
| | - V. Gattei
- Clinical and Experimental Onco-Haematology Unit; Centro di Riferimento Oncologico, IRCCS; Aviano Italy
| | - M. Manni
- Dipartimento Chirurgico, Medico, Odontoiatrico e di Scienze Morfologiche; University of Modena and Reggio Emilia; Modena Italy
| | - S. Pileri
- Divisione di Diagnosi Ematopatologica; Istituto Europeo di Oncologia; Milano Italy
| | - M. Brugiatelli
- UOC di Ematologia; Azienda Ospedaliera Papardo; Messina Italy
| | - S. Luminari
- S.C. Ematologia; Arcispedale S. Maria Nuova-IRCCS; Reggio Emilia Italy
| |
Collapse
|
11
|
Chauvie S, Dalmasso F, Pierce L, Vitolo U, Martelli M, Sehn L, Trněný M, Nielsen T, Sahin D, Lee C, Mattiello F, Berchialla P, Kinahan P, Kostakoglu L. RADIOMICS INCREASE THE PROGNOSTIC VALUE OF CLINICAL AND PET RISK FACTORS IN DLBCL: RESULTS FROM THE PHASE 3 GOYA STUDY. Hematol Oncol 2019. [DOI: 10.1002/hon.21_2629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- S. Chauvie
- Medical Physics Division; Santa Croce e Carle Hospital; Cuneo Italy
| | - F. Dalmasso
- Medical Physics Division; Santa Croce e Carle Hospital; Cuneo Italy
| | - L. Pierce
- Department of Radiology; University of Washington; Seattle WA United States
| | - U. Vitolo
- Department of Oncology and Haematology; Azienda Ospedaliera-Universitaria Città della Salute e della Scienza; Turin Italy
| | - M. Martelli
- Department of Translational and Precision Medicine; Sapienza University of Rome; Rome Italy
| | - L.H. Sehn
- Medical Oncology; University of British Columbia; Vancouver Canada
| | - M. Trněný
- 1st Department of Medicine - Department of Haematology; Charles University General Hospital; Prague Czech Republic
| | - T. Nielsen
- Product Development Oncology; F. Hoffmann-La Roche Ltd.; Basel Switzerland
| | - D. Sahin
- Product Development Oncology; F. Hoffmann-La Roche Ltd.; Basel Switzerland
| | - C. Lee
- Product Development Oncology; Genentech, Inc.; South San Francisco United States
| | - F. Mattiello
- Product Development Oncology; F. Hoffmann-La Roche Ltd.; Basel Switzerland
| | - P. Berchialla
- Clinical and Biological Sciences; University of Turin; Turin Italy
| | - P.E. Kinahan
- Department of Radiology; University of Washington; Seattle WA United States
| | - L. Kostakoglu
- Department of Radiology; Icahn School of Medicine; New York United States
| |
Collapse
|
12
|
Guerra L, Bergesio F, Versari A, Franceschetto A, Peano S, Fallanca F, Storto G, Luminari S, Rigacci L, Gallamini A, Federico M, Chauvie S. INTERIM ANALYSIS OF CENTRAL REVIEW OF END-OF-THERAPY PET IN FOLL12 TRIAL FOR FOLLICULAR LYMPHOMA. Hematol Oncol 2019. [DOI: 10.1002/hon.62_2631] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- L. Guerra
- Nuclear Medicine; San Gerardo Hospital - ASST Monza; Monza Italy
| | - F. Bergesio
- Medical Physics; Azienda Ospedaliera S. Croce e Carle; Cuneo Italy
| | - A. Versari
- Nuclear Medicine; AUSL-IRCCS of Reggio Emilia; Reggio Emilia Italy
| | - A. Franceschetto
- Nuclear Medicine; University of Modena and Reggio Emilia; Modena Italy
| | - S. Peano
- Nuclear Medicine; Azienda Ospedaliera S. Croce e Carle; Cuneo Italy
| | - F. Fallanca
- Nuclear Medicine; San Raffaele Scientific Institute; Milano Italy
| | - G. Storto
- Nuclear Medicine; IRCCS-CROB Referral Cancer Center of Basilicata; Rionero in Vulture Italy
| | - S. Luminari
- Department of Diagnostic Medicine; Clinical and Public Health, University of Modena and Reggio Emilia; Modena Italy
| | - L. Rigacci
- Haematology and Stem Cells Transplantation Unit; San Camillo Forlanini Hospital; Roma Italy
| | - A. Gallamini
- Research and Clinical Innovation; Antoine Lacassagne Cancer Center; Nice France
| | - M. Federico
- CHIMOMO; University of Modena and Reggio Emilia; Modena Italy
| | - S. Chauvie
- Medical Physics; Azienda Ospedaliera S. Croce e Carle; Cuneo Italy
| |
Collapse
|
13
|
Mazza R, Spina M, Califano C, Gaudio F, Carella M, Consoli U, Palombi F, Musso M, Pulsoni A, Kovalchuk S, Bonfichi M, Ricci F, Fabbri A, Liberati A, Rodari M, Giordano L, Balzarotti M, Gallamini A, Ricardi U, Chauvie S, Merli F, Carlo-Stella C, Santoro A. DOSE DENSE ABVD (DD-ABVD) AS FIRST LINE THERAPY IN EARLY-STAGE UNFAVORABLE HODGKIN LYMPHOMA (HD): RESULTS OF A PHASE II, PROSPECTIVE STUDY BY FONDAZIONE ITALIANA LINFOMI. Hematol Oncol 2019. [DOI: 10.1002/hon.100_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- R. Mazza
- Medical Oncology and Hematology Department; Humanitas Research Hospital; Rozzano-Milano Italy
| | - M. Spina
- Medical Oncology Division; Centro Riferimento Oncologico; Aviano Italy
| | - C. Califano
- Onco-Hematology Department; A. Tortora Hospital; Pagani Italy
| | - F. Gaudio
- Emergency and Transplantation Department; Hematology section, University of Bari; Bari Italy
| | - M. Carella
- Hematological Consultant; Casa di Cura La Madonnina; Milano Italy
| | - U. Consoli
- Garibaldi Nesima Hospital; Hematology Department; Catania Italy
| | - F. Palombi
- Hematology Department; Regina Elena National Cancer Institute; Roma Italy
| | - M. Musso
- Onco-Hematology Unit; Casa di Cura “La Maddalena”; Palermo Italy
| | - A. Pulsoni
- Cellular Biotechnologies and Hematology Department; Policlinico Umberto I, Sapienza University; Rome Italy
| | - S. Kovalchuk
- Hematology Department; AOU Carreggi; Firenze Italy
| | - M. Bonfichi
- Hematology Division; IRCCS Policlinico S. Matteo; Pavia Italy
| | - F. Ricci
- Medical Oncology and Hematology Department; Humanitas Research Hospital; Rozzano-Milano Italy
| | - A. Fabbri
- Hematology Unit; AOU Senese; Siena Italy
| | - A. Liberati
- Onco-Hematology Division; S. Maria Hospital; Terni Italy
| | - M. Rodari
- Humanitas Reserch Hospital; Nuclear Medicin Unit; Rozzano-Milano Italy
| | - L. Giordano
- Biostatistic Unit; Humanitas Research Hospital; Rozzano Milano Italy
| | - M. Balzarotti
- Medical Oncology and Hematology Department; Humanitas Research Hospital; Rozzano-Milano Italy
| | - A. Gallamini
- Research; Innovation and Statistc Depatment, Centre Antoine-Lacassagne; Nice France
| | - U. Ricardi
- Oncology Department; Radiation Oncology, University of Torino; Torino Italy
| | - S. Chauvie
- Medical Physics Department; S Croce e Carle Hospital; Cuneo Italy
| | - F. Merli
- Hematology Department; Arcispedale Santa Maria Nuova; Reggio Emilia Italy
| | - C. Carlo-Stella
- Medical Oncology and Hematology Department; Humanitas University; Rozzano-Milano Italy
| | - A. Santoro
- Medical Oncology and Hematology Department; Humanitas University; Rozzano-Milano Italy
| |
Collapse
|
14
|
Matheoud R, Bergesio F, Chiesa C, De Ponti E, Morzenti S, Ragazzoni M, Chauvie S. 80. Advancements in PET image reconstruction algorithms: Preliminary results of their application. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
15
|
Chauvie S. Abstract ID: 375 Quantitative imaging in nuclear medicine. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
16
|
De Maggi A, Acchiardi N, Bergesio F, Roberto E, Chauvie S. 356. ZeroDose: An automatic tool for exposure indexes retrieval from images stored in PACS system. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
17
|
Chauvie S, Acchiardi N, De Maggi A, Roberto E, Bergesio F. 241. Radiation risk due to medical imaging in long living patients: the case of Hodgkin lymphoma. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.252] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
18
|
Roberto E, Gonnet R, Barberis M, Maggi AD, Bergesio F, Baralis I, Grosso M, Chauvie S. 280. VATS (Video Assisted Thoracoscopic Surgery) with radiological guidance in hybrid operating room: Technique standardization, organizational aspects and dose optimization. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
19
|
Bergesio F, Biggi A, Coronado M, Ceriani L, Chauvie S. 326. PET scanner qualification for clinical trial: Comparison between Italian and worldwide experience. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
20
|
Zaucha JM, Malkowski B, Chauvie S, Subocz E, Tajer J, Kulikowski W, Fijolek-Warszewska A, Biggi A, Fallanca F, Kobylecka M, Dziuk M, Woszczyk D, Rybka J, Kroll-Balcerzak R, Bergesio F, Romanowicz A, Chamier-Cieminska A, Kurczab P, Giza A, Lesniewski-Kmak K, Zaucha R, Swietlik D, Wróbel T, Knopinska-Posluszny W, Walewski J, Gallamini A. The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin's lymphoma patients-the Polish Lymphoma Research Group (PLRG) Observational Study. Ann Oncol 2018; 28:3051-3057. [PMID: 28950332 DOI: 10.1093/annonc/mdx524] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Background Interim PET after two ABVD cycles (iPET2) predicts treatment outcome in classical Hodgkin's lymphoma. To test whether an earlier assessment of chemosensitivity would improve the prediction accuracy, we launched a prospective, multicenter observational study aimed at assessing the predictive value of iPET after one ABVD (iPET1) and the kinetics of response assessed by sequential PET scanning. Patients and methods Consecutive patients with newly diagnosed classical Hodgkin's lymphoma underwent interim PET scan after one ABVD course (iPET1). PETs were interpreted according to the Deauville score (DS) as negative (-) (DS 1-3) and positive (+) (DS 4, 5). Patients with iPET1 DS 3-5 underwent iPET2. Results About 106 early (I-IIA) and 204 advanced (IIB-IV) patients were enrolled between January 2008 and October 2014. iPET1 was (-) in 87/106 (82%) or (+) in 19/106 (18%) of early, and (-) in 133/204 (65%) or (+) in 71/204 (35%) of advanced stage patients, respectively. Twenty-four patients were excluded from response analysis due to treatment escalation. After a median follow-up of 38.2 (3.2-90.2) months, 9/102 (9%) early and 43/184 (23%) advanced patients experienced a progression-free survival event. At 36 months, negative and positive predictive value for iPET1 were 94% and 41% (early) and 84% and 43% (advanced), respectively. The kinetics of PET response was assessed in 198 patients with both iPETs. All 116 patients with iPET1(-) remained iPET2(-) (fast responders), 41/82 with IPET1(+) became iPET2(-) (slow responders), and the remaining 41 stayed iPET2(+) (non-responders); progression-free survival at 36 months for fast, slow and non-responders was 0.88, 0.79 and 0.34, respectively. Conclusion The optimal tool to predict ABVD outcome in HL remains iPET2 because it distinguishes responders, whatever their time to response, from non-responders. However, iPET1 identified fast responders with the best outcome and might guide early treatment de-escalation in both early and advanced-stage HL.
Collapse
Affiliation(s)
- J M Zaucha
- Gdynia Oncology Center, Gdynia.,Departments of Oncological Propedeutics.,Hematology and Transplantology, Medical University of Gdańsk, Gdańsk
| | - B Malkowski
- Nuclear Medicine Department, Oncology Center, Bydgoszcz.,Positron Emission Tomography and Molecular Imagining Department, Collegium Medicum N. Copernicus University, Bydgoszcz, Poland
| | - S Chauvie
- Medical Physics Department, Santa Croce e Carle Hospital, Cuneo, Italy
| | - E Subocz
- Department of Hematology, Military Institute of Medicine, Warszawa
| | - J Tajer
- Department of Lymphoproliferative Diseases, Maria Sklodowska-Curie Memorial Institute, Warszawa
| | - W Kulikowski
- Clinical Department of Hematology, Interior Ministry Hospital, Warmia.,Mazury Medical University, Olsztyn
| | | | - A Biggi
- Nuclear Medicine Department, Santa Croce e Carle Hospital, Cuneo
| | - F Fallanca
- Nuclear Medicine Department, San Raffaele Hospital, Milano, Italy
| | - M Kobylecka
- Nuclear Medicine Department, Warsaw Medical University, Warszawa
| | - M Dziuk
- Nuclear Medicine Department, Military Institute of Medicine, Warszawa
| | - D Woszczyk
- Hematology Unit, Regional Hospital, Opole
| | - J Rybka
- Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw
| | | | - F Bergesio
- Medical Physics Department, Santa Croce e Carle Hospital, Cuneo, Italy
| | - A Romanowicz
- Department of Hematology, Central Clinical Hospital MSW, Warszawa
| | | | - P Kurczab
- Poradnia Onkologiczna z Oddzialem Chemioterapii Dziennej NZOZ Mrukmed, Rzeszów
| | - A Giza
- Department of Hematology, Jagiellonian University Medical College, Krakow
| | - K Lesniewski-Kmak
- Gdynia Oncology Center, Gdynia.,Departments of Oncological Propedeutics.,Hematology and Transplantology, Medical University of Gdańsk, Gdańsk
| | - R Zaucha
- Department of Clinical Oncology and Radiotherapy
| | - D Swietlik
- Intrafaculty College of Medical Informatics & Biostatistics, Medical University of Gdansk, Poland
| | - T Wróbel
- Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw
| | - W Knopinska-Posluszny
- Clinical Department of Hematology, Interior Ministry Hospital, Warmia.,Mazury Medical University, Olsztyn
| | - J Walewski
- Department of Lymphoproliferative Diseases, Maria Sklodowska-Curie Memorial Institute, Warszawa
| | - A Gallamini
- Department of Research, Innovation and Statistics, A. Lacassagne Cancer Center, Nice, France
| |
Collapse
|
21
|
Bertone E, Bergesio F, Terulla A, Cerello P, Chauvie S. Application of LIDEA (LIver DEtection Algorithm) for PET/CT scans. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.339] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
22
|
Bergesio F, Terulla A, Guerra D, Bertone E, Chauvie S. Impact of uptake time in physiological compartments for PET/CT examination. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
23
|
Chauvie S, Bergesio F, Fioroni F, Brambilla M. PET scanner clinical trial qualification with 68Ge-filled NEMA/IEC image quality phantom outperforms with respect to 18F. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
24
|
Lucio F, Calamia E, Boriano A, Fillini C, Melano A, Gerbino A, Dutto A, Chauvie S. A proactive study of risk applied to the planning process for IMRT/VMAT treatments. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
25
|
Bergesio F, Terulla A, Bertone E, Chauvie S. Application of standardized procedure enhances reliability of SUV data in PET/CT studies. Phys Med 2016. [DOI: 10.1016/j.ejmp.2016.01.337] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
26
|
Mauro FR, Chauvie S, Paoloni F, Biggi A, Cimino G, Rago A, Gentile M, Morabito F, Coscia M, Bellò M, Sacchetti GM, Rossi D, Laurenti L, Autore F, Campanelli M, Trastulli F, Nicolai E, Riminucci M, Gaidano G, Guarini A, Gallamini A, Foà R. Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease. Leukemia 2015; 29:1360-5. [DOI: 10.1038/leu.2015.21] [Citation(s) in RCA: 45] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2014] [Revised: 10/25/2014] [Accepted: 12/10/2014] [Indexed: 11/09/2022]
|
27
|
Bertolaccini L, Lanzi E, Viti A, Chauvie S, Bianchi A, Cavallo A, Terzi A. 37O 18-F FDG PET TOTAL GLYCOLYTIC VOLUME IN THYMIC EPITHELIAL NEOPLASMS EVALUATION: AN EASILY REPRODUCIBLE IMAGE BIOMARKER. Lung Cancer 2013. [DOI: 10.1016/s0169-5002(13)70258-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
28
|
Gallamini A, Biggi A, Chauvie S, Bianchi A, Conti S, Fiore F, Sorasio R, Vose J, Thomas DL, Juweid ME. Does a negative post-therapy PET obviate the need for any further follow-up imaging in patients with nonbulky early-stage Hodgkin's lymphoma (HL)? J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.8058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
29
|
Chauvie S, Incerti S, Moretto P, Pia MG. Evaluation of phase effects in Geant4 microdosimetry models for particle interactions in water. ACTA ACUST UNITED AC 2007. [DOI: 10.1109/nssmic.2007.4436472] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
30
|
Macias V, Chauvie S, Malinverni G, Munoz-H F, Stasi M, Scielzo G, Gabriele P. Can dynamic intensity-modulated radiotherapy be a valid treatment option of vertebral chordoma in institutions where proton therapy is not disposable. Int J Radiat Oncol Biol Phys 2002. [DOI: 10.1016/s0360-3016(02)03568-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
31
|
Chauvie S, Cirio R, Donetti M, Marchetto F, Peroni C. A Monte Carlo model for cell-cycle kinetics in charged particle irradiation. Phys Med 2002; 17 Suppl 1:175-6. [PMID: 11771550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/23/2023] Open
Abstract
In this paper we present a simulation of cell survival in Hadrontherapy. The work based on the Scholz-Kraft model extends the original approach to account both for the cell dimensions and radiosensitivity as a function of the time along the cell cycle.
Collapse
Affiliation(s)
- S Chauvie
- INFN, Sezione di Torino, Universita di Torino, Torino, Italy
| | | | | | | | | |
Collapse
|